Bpifrance

Bpifrance is a financial institution dedicated to supporting companies throughout their development stages, particularly those preparing for stock market listing and seeking credit equity. The organization provides a range of financial solutions, including financing, innovation assistance, and capital investment. By integrating various entities such as OSEO and CDC Entreprises, Bpifrance aims to deliver tailored financial support that addresses the specific needs of businesses. The institution is committed to fostering innovation and helping companies transition toward sustainable growth, ensuring they are well-equipped to face future challenges.

Marion Aubry

Investment Director

Emmanuel Audouard

Director of Transverse Venture Capital Investments Division

Maufras Du Chatellier, Elyssa

Investment Director

Charlotte Corbaz

Investment Drector - Large Venture

Dahoune, Sofia

Associate

Vanessa Giraud

Director of Environmental Impact Funds

Gwenaël Hamon

Investment Director

Laurent Higueret

Senior Investment Director, Healthcare and Life Sciences - Large Venture Fund

Jacq, Véronique

Head of Digital Venture team

So-Yeon Koo

Senior Investment Manager

Eric Lefebvre

Director

Legardeur, Arnaud

Investment Director

Serge Mesguich

Director of FIT

Louis Molis

Investment Director

Adrien Neel

Investment Director

Gilles Schang

Deputy Managing Director

Past deals in Health Care

Maddie

Venture Round in 2023
Maddie provides patient and practice management software solutions for physiotherapists.

Ludocare

Seed Round in 2022
Ludocare is to create ways to provide assistance to patients and their families to improve their abilities, autonomy, and quality of life.

Ribonexus

Debt Financing in 2022
Ribonexus is a biotechnology company dedicated to developing innovative therapies aimed at treating cancer, particularly melanoma. The company is focused on creating a pipeline of small molecules that target the eukaryotic translation Initiation Factor-4A (eIF4A), which plays a significant role in various solid and hematologic cancers. This target is particularly relevant for addressing resistance to existing treatments, which often diminishes the effectiveness of targeted therapies. Ribonexus aims to produce drugs that can restore sensitivity to these therapies in patients who have developed resistance, thereby improving treatment outcomes in oncology.

Ribonexus

Grant in 2022
Ribonexus is a biotechnology company dedicated to developing innovative therapies aimed at treating cancer, particularly melanoma. The company is focused on creating a pipeline of small molecules that target the eukaryotic translation Initiation Factor-4A (eIF4A), which plays a significant role in various solid and hematologic cancers. This target is particularly relevant for addressing resistance to existing treatments, which often diminishes the effectiveness of targeted therapies. Ribonexus aims to produce drugs that can restore sensitivity to these therapies in patients who have developed resistance, thereby improving treatment outcomes in oncology.

Guard Medical

Series B in 2022
Guard Medical is a medical device company that specializes in developing innovative solutions for wound care. Its primary product, NPseal™, is designed for prophylactic negative pressure wound therapy (NPWT) of closed surgical incisions. This device aims to reduce surgical site infections and improve the healing process by establishing and maintaining negative pressure with minimal effort. By integrating an easy-to-use pump, NPseal™ allows patients to effectively prevent infection and minimize scarring, ultimately enhancing the cosmetic outcomes of surgical wounds. The company focuses on creating cost-effective alternatives that prioritize patient care and recovery.

Doctolib

Series F in 2022
Doctolib is an online healthcare booking platform and management software provider. For doctors, Doctolib offers a full-range service to improve bookings management, reduce no-show, and bring new patients to their office. For patients, Doctolib is a free online service to find a nearby health practitioner and book doctors or dental appointments 24/7 within a few clicks. Founded in 2013, Doctolib is based in Paris, France.

SeaBeLife

Grant in 2022
SeaBeLife Biotech SAS is a biotechnology company based in Roscoff, France, established in 2019. The company focuses on developing innovative drug candidates aimed at treating acute pathologies, particularly acute liver and renal failure. SeaBeLife's products are derived from a family of patented molecules designed to block regulated necrosis, a type of regulated cell death. By targeting two synergistic pathways involved in various acute and chronic diseases, SeaBeLife aims to establish a new standard of care for patients with significant unmet medical needs. Through its research and development efforts, the company seeks to enhance patient outcomes and reduce complications associated with serious health conditions.

Susu

Debt Financing in 2022
Susu is a dynamic and innovative company that offers a wide range of health services for families in the African diaspora. Susu provides a complete offer on Preventive care, Medical treatments, Management of chronic diseases, and Authentic drugs.

Susu

Grant in 2022
Susu is a dynamic and innovative company that offers a wide range of health services for families in the African diaspora. Susu provides a complete offer on Preventive care, Medical treatments, Management of chronic diseases, and Authentic drugs.

Cureety

Series A in 2022
Cureety is a telemedicine startup that improves the follow-up and care of patients.

Heroic sante

Seed Round in 2022
Heroic Sante is a virtual platform. They offer patients the chance to have their questions answered by qualified carers and learn from other patients. Their community works to create useful projects for patients and finances them thanks to statements on applications.

Fysali

Grant in 2021
Fysali breaks the taboo by providing remote, non-invasive bladder monitoring. They offer superior clinical accuracy, an exceptional patient experience, and a lower cost of care. They offer remote and noninvasive bladder monitoring services.

Omnidoc

Seed Round in 2021
Omnidoc is a tele-expertise platform for healthcare professionals to exchange medical opinions.

Arkhn

Series A in 2021
Arkhn is a company focused on healthcare data interoperability, addressing challenges related to accessing and managing healthcare data. It develops medical enterprise software that standardizes healthcare information to enhance patient care and support medical teams. By improving data accessibility, Arkhn aims to facilitate medical research and innovation while streamlining the operations of healthcare centers. This enables healthcare establishments to provide better support for patients and caregivers, ultimately accelerating advancements in the healthcare sector.

GRAPHEAL

Seed Round in 2021
Grapheal is a Medtech startup, which produces embedded and wearable biosensors, digital by design, minimalistic in components, with capabilities to dose biomarkers and detect pathogens anywhere with a simple smartphone. Wireless electronic biosensors produced by Grapheal are based on graphene transistors which make field diagnostics and remote patient monitoring affordable & accurate.

Weliom

Venture Round in 2021
Weliom offers digital healthcare consulting services in France.

Fysali

Grant in 2021
Fysali breaks the taboo by providing remote, non-invasive bladder monitoring. They offer superior clinical accuracy, an exceptional patient experience, and a lower cost of care. They offer remote and noninvasive bladder monitoring services.

Medaviz

Series A in 2020
Medaviz is an online platform founded in 2014 and headquartered in Paris, France, that facilitates immediate communication between patients and healthcare professionals. The service allows users to connect with various specialists, including general practitioners, pediatricians, gynecologists, and psychologists, at any time. By providing access to medical advice around the clock, Medaviz enables users to address their medical issues or emergencies efficiently, enhancing the convenience of healthcare access.

SeaBeLife

Seed Round in 2020
SeaBeLife Biotech SAS is a biotechnology company based in Roscoff, France, established in 2019. The company focuses on developing innovative drug candidates aimed at treating acute pathologies, particularly acute liver and renal failure. SeaBeLife's products are derived from a family of patented molecules designed to block regulated necrosis, a type of regulated cell death. By targeting two synergistic pathways involved in various acute and chronic diseases, SeaBeLife aims to establish a new standard of care for patients with significant unmet medical needs. Through its research and development efforts, the company seeks to enhance patient outcomes and reduce complications associated with serious health conditions.

Ambler

Series A in 2020
Ambler is a startup founded in 2018 by experts in digital and so-called "marketplace" models 100% French, the company enjoys the support of public authorities (Wilco-ex Scientipôle) and the support of prestigious private investors , including Partech, Idinvest Partners, Kima Ventures. The startup is developing technologies to help match the supply and demand of medical transports. It aggregates, thanks to win-win partnerships, a considerable fleet of vehicles and offers unparalleled deliverability for contractors. Ambler is the only solution capable, nationwide, of absorbing the constant growth of health transport flows induced by demographic and regulatory factors (reform of regional hospital groups).

Cureety

Seed Round in 2020
Cureety is a telemedicine startup that improves the follow-up and care of patients.

Spellz

Seed Round in 2020
Customer Service meets Generative AI

Doctolib

Series E in 2019
Doctolib is an online healthcare booking platform and management software provider. For doctors, Doctolib offers a full-range service to improve bookings management, reduce no-show, and bring new patients to their office. For patients, Doctolib is a free online service to find a nearby health practitioner and book doctors or dental appointments 24/7 within a few clicks. Founded in 2013, Doctolib is based in Paris, France.

Happytal

Debt Financing in 2018
Happytal, SAS offers concierge services to hospitals in France. Its services include providing a hairdresser in the room, a beautician, to receive the newspaper, and to offer a basket of fruits and meals. The company was founded in 2013 and is based in Vanves, France.

Doctoconsult

Venture Round in 2018
Doctoconsult provides online heath care consultation services. E-Mental health startup. First video consultation service dedicated to psychiatrists and their patients in France. Today launching an innovated app co-designed by KOL physicians & researchers to help patients suffering from mental disorders.

Doctolib

Series D in 2017
Doctolib is an online healthcare booking platform and management software provider. For doctors, Doctolib offers a full-range service to improve bookings management, reduce no-show, and bring new patients to their office. For patients, Doctolib is a free online service to find a nearby health practitioner and book doctors or dental appointments 24/7 within a few clicks. Founded in 2013, Doctolib is based in Paris, France.

Doctolib

Series C in 2017
Doctolib is an online healthcare booking platform and management software provider. For doctors, Doctolib offers a full-range service to improve bookings management, reduce no-show, and bring new patients to their office. For patients, Doctolib is a free online service to find a nearby health practitioner and book doctors or dental appointments 24/7 within a few clicks. Founded in 2013, Doctolib is based in Paris, France.

H4D

Series B in 2016
H4D, founded in 2008, is dedicated to overcoming barriers to healthcare access, whether they stem from geographic isolation or social circumstances. The company focuses on providing preventive care and managing chronic diseases through innovative telemedicine solutions. Its global telemedicine software connects patients with healthcare professionals, particularly targeting individuals in underserved areas, employees in corporate settings, seniors in group housing, and students who require medical assistance. H4D aims to make health checks accessible to all, ensuring that healthcare solutions are integrated into comprehensive health plans and supported by communication with local healthcare stakeholders. Through its commitment to inclusivity and collaboration with medical professionals, H4D strives to enhance healthcare accessibility and improve health outcomes for diverse populations.

MediPole Partenaires

Private Equity Round in 2016
MédiPôle Partenaires is a group of private clinics whose competence is particularly recognized in the fields of Medicine of Obstetric Surgery (MCO), Continuing Care and Rehabilitation (SSR) and Home Hospitalization (HAD).

SYNAP6

Seed Round in 2016
SYNAP6 is operates a nursing home for the elderly and persons with disabilities.

LINK CARE SERVICES

Seed Round in 2012
LINK CARE SERVICES offers clinical and pastoral counseling services and restores the whole person, mind, body, and soul. In addition, they also provide studios and one-bedroom apartments to seniors 55 years of age and older. The company's contact modes are mail, phone, and physical address.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.